NCT07428044: A Study of Trastuzumab Deruxtecan in People With Non-Small Cell Lung Cancer

Sponsor: Memorial Sloan Kettering Cancer Center. Phase: PHASE2. Conditions: Non-Small Cell Lung Cancer, Non-small Cell Lung Cancer Stage II, Non-Small Cell Lung Cancer Stage IIIA, Non-Small Cell Lung Cancer Stage IIIB